Clinical Trial Update: Safety and Immunogenicity of a Candidate Tuberculosis (TB) Vaccine in Adults With TB Disease [Phase 2]

View source ↗

Summary

Phase 2 trial assessing safety and immunogenicity of a candidate TB vaccine in adults with tuberculosis has been terminated with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tuberculosis

Drugs mentioned

• GlaxoSmithKline candidate tuberculosis vaccine

Snippet

Sponsor: GlaxoSmithKline | Conditions: Tuberculosis | Phase 2 | Status: TERMINATED | Results posted: 2017-01-24